Stock NBY NOVABAY PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NovaBay Pharmaceuticals, Inc.

Equities

NBY

US66987P3001

Real-time Estimate Cboe BZX
Other stock markets
 17:44:25 24/05/2024 BST 		5-day change 1st Jan Change
0.136 USD -2.86% Intraday chart for NovaBay Pharmaceuticals, Inc. +14.50% -33.43%
05-09 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q1 Revenue $2.63M, vs. Street Est of $3.28M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NOVABAY PHARMACEUTICALS, INC. Stock NovaBay Pharmaceuticals, Inc.
 5.05M - - -
MODERNA, INC. Stock Moderna, Inc.
 62.86B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.38B
LONZA GROUP AG Stock Lonza Group AG
 40.38B
CELLTRION, INC. Stock Celltrion, Inc.
 27.64B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.46B
  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Charts NovaBay Pharmaceuticals, Inc.
  5. Sector Chart